Exact Sciences Corp. (EXAS) Social Stream
EXACT SCIENCES CORP (EXAS) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering EXACT SCIENCES CORP.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 13 | $165 | $95 | $143.583 | $68.64 | 109.18% |
| 2021-12-08 | 13 | $163 | $95 | $140.25 | $68.64 | 104.33% |
| 2022-01-04 | 13 | $163 | $95 | $139.25 | $68.64 | 102.87% |
| 2022-01-06 | 13 | $163 | $95 | $138 | $68.64 | 101.05% |
| 2022-01-18 | 13 | $163 | $95 | $136.5 | $68.64 | 98.86% |
| 2022-02-23 | 12 | $160 | $90 | $130.454 | $68.64 | 90.06% |
| 2022-02-24 | 12 | $160 | $90 | $125 | $68.64 | 82.11% |
| 2022-04-26 | 12 | $160 | $90 | $124.09 | $68.64 | 80.78% |
| 2022-04-28 | 11 | $160 | $65 | $104.714 | $68.64 | 52.56% |
| 2022-06-03 | 12 | $160 | $50 | $98.4 | $68.64 | 43.36% |
| 2022-07-19 | 9 | $95 | $50 | $79.083 | $68.64 | 15.21% |
| 2022-08-03 | 12 | $95 | $50 | $79.083 | $68.64 | 15.21% |
| 2022-08-13 | 13 | $95 | $50 | $71.307 | $68.64 | 3.89% |
| 2022-09-17 | 13 | $95 | $40 | $70.538 | $68.64 | 2.77% |
| 2022-10-17 | 13 | $95 | $40 | $69 | $68.64 | 0.52% |
| 2022-10-24 | 13 | $95 | $40 | $69.75 | $68.64 | 1.62% |
| 2022-11-04 | 13 | $85 | $40 | $67.454 | $68.64 | -1.73% |
| 2022-11-07 | 13 | $85 | $35 | $63.545 | $68.64 | -7.42% |
| 2022-11-08 | 13 | $85 | $35 | $62.636 | $68.64 | -8.75% |
| 2022-11-14 | 13 | $85 | $35 | $63.545 | $68.64 | -7.42% |
| 2022-12-04 | 13 | $85 | $35 | $61.09 | $68.64 | -11% |
| 2022-12-15 | 12 | $85 | $35 | $61.09 | $68.64 | -11% |
| 2023-01-06 | 12 | $85 | $35 | $62.545 | $68.64 | -8.88% |
| 2023-01-12 | 12 | $85 | $35 | $61.545 | $68.64 | -10.34% |
| 2023-02-08 | 12 | $85 | $35 | $63.181 | $68.64 | -7.95% |
| 2023-02-21 | 13 | $85 | $35 | $63.181 | $68.64 | -7.95% |
| 2023-02-23 | 13 | $92 | $50 | $74.166 | $68.64 | 8.05% |
| 2023-03-03 | 13 | $92 | $55 | $75.833 | $68.64 | 10.48% |
| 2023-03-09 | 13 | $92 | $55 | $77.5 | $68.64 | 12.91% |
| 2023-04-21 | 13 | $92 | $55 | $76.818 | $68.64 | 11.91% |
| 2023-05-10 | 14 | $92 | $55 | $77.333 | $68.64 | 12.66% |
| 2023-05-11 | 14 | $99 | $70 | $84.916 | $68.64 | 23.71% |
| 2023-05-14 | 14 | $99 | $73 | $85.75 | $68.64 | 24.93% |
| 2023-06-06 | 14 | $95 | $73 | $87 | $68.64 | 26.75% |
| 2023-06-07 | 14 | $100 | $73 | $88.5 | $68.64 | 28.93% |
| 2023-06-20 | 15 | $100 | $73 | $88.5 | $68.64 | 28.93% |
| 2023-06-22 | 15 | $130 | $73 | $98.666 | $68.64 | 43.74% |
| 2023-06-23 | 15 | $130 | $73 | $105.153 | $68.64 | 53.19% |
| 2023-07-24 | 16 | $130 | $73 | $105.5 | $68.64 | 53.7% |
| 2023-08-01 | 16 | $130 | $73 | $105.5 | $68.64 | 53.7% |
| 2023-08-03 | 16 | $130 | $73 | $109.357 | $68.64 | 59.32% |
| 2023-08-08 | 16 | $130 | $73 | $110.071 | $68.64 | 60.36% |
| 2023-09-28 | 17 | $130 | $73 | $108.266 | $68.64 | 57.73% |
| 2023-10-10 | 17 | $130 | $73 | $108.266 | $68.64 | 57.73% |
| 2023-10-15 | 17 | $130 | $73 | $107.6 | $68.64 | 56.76% |
| 2023-10-20 | 17 | $130 | $73 | $106.133 | $68.64 | 54.62% |
| 2023-11-03 | 17 | $130 | $73 | $102.466 | $68.64 | 49.28% |
| 2023-11-06 | 17 | $130 | $73 | $100.6 | $68.64 | 46.56% |
The Trend in the Analyst Price Target
EXAS's average price target has moved up $21.52 over the prior 15 months.
EXAS reports an average of 16.34% for its upside potential over the past 43 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-26 | 12 | 85 | 35 | 63.181 | 65.04 | -2.86% |
| 2023-02-23 | 13 | 92 | 50 | 74.166 | 61.63 | 20.34% |
| 2023-06-07 | 15 | 100 | 73 | 88.500 | 87.76 | 0.84% |
| 2023-06-20 | 15 | 120 | 73 | 91.000 | 94.34 | -3.54% |
| 2023-06-22 | 15 | 130 | 73 | 98.666 | 95.05 | 3.8% |
EXAS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.35 | 14 | 0 | 3 | 0 | 0 | 17 |
The Trend in the Broker Recommendations
EXAS's average broker recommendation rating worsened by 0.1 over the prior 17 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for EXAS as an investment opportunity.
- EXACT SCIENCES CORP's number of analysts covering the stock is higher than 4269.43% of all US stocks.
- In the context of all US stocks, EXACT SCIENCES CORP's upside potential (average analyst target price relative to current price) is higher than 3076.74% of them.
- To contextualize these metrics, consider that out of Healthcare stocks, EXACT SCIENCES CORP's average analyst price target is greater than 4550.56% of them.
- To contextualize these metrics, consider that out of stocks in the large market cap category, EXACT SCIENCES CORP's variance in analysts' estimates is lower than -3904.49% of them.
Stocks similar to EXACT SCIENCES CORP in the Business Services industry regarding analyst recommendations and price targets are CRL, INCY, and WSC.
View All Top Stocks by Price Target
Is EXAS a Buy, Hold or Sell? See the POWR Ratings now!